{"id":"W2037806696","doi":"10.1038/ncprheum0880","title":"Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis","year":2008,"lang":"en","type":"letter","venue":"Nature Clinical Practice Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Etanercept; Medicine; Adalimumab; Psoriatic arthritis; Infliximab; Psoriasis; Placebo; Internal medicine; Rheumatoid arthritis; Rheumatology; Dermatology; Tumor necrosis factor alpha; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007369791,0.0008294964,0.002820435,0.0003053621,0.0003403017,0.00008364692,0.0002701108,0.004413385,0.00007876649],"category_scores_gemma":[0.03026661,0.000624807,0.0004274345,0.0002200748,0.0009595284,0.0004423397,0.000128669,0.008165127,0.00007761192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001463068,"about_ca_system_score_gemma":0.0004995175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004779176,"about_ca_topic_score_gemma":0.00003964528,"domain_scores_codex":[0.9936675,0.001364578,0.001436473,0.001429203,0.001045444,0.001056811],"domain_scores_gemma":[0.9698029,0.02615431,0.001418914,0.000822227,0.001415002,0.0003866771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01177153,0.002067813,0.03634098,0.0006813819,0.005977142,0.002857385,0.0002527425,1.873732e-7,2.494733e-7,0.0001395362,0.75293,0.1869811],"study_design_scores_gemma":[0.03497194,0.009597232,0.02386032,0.001989103,0.0003765708,0.003187313,0.00009059367,0.00001287601,0.000001324364,0.0003004648,0.9249355,0.000676811],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.1413747,0.1194571,0.000225819,0.7176242,0.003982113,0.01478985,0.0008693881,0.00044623,0.001230491],"genre_scores_gemma":[0.1017375,0.3569097,0.01622757,0.5153003,0.002202976,0.002213803,0.003928985,0.000625469,0.0008537339],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.2374525,"threshold_uncertainty_score":0.9996203,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01407566660361872,"score_gpt":0.3488632714093511,"score_spread":0.3347876048057324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}